Fractyl Health Inc (GUTS)

Currency in USD
1.01
-0.86(-45.99%)
Closed·
After Hours
0.99-0.02(-1.99%)
·
GUTS Scorecard
Full Analysis
Quickly burning through cash
Unusual trading volume
Trading near 52-week Low
Earnings results expected in 0 days
GUTS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.831.05
52 wk Range
0.833.72
Key Statistics
Prev. Close
1.87
Open
0.99
Day's Range
0.83-1.05
52 wk Range
0.83-3.72
Volume
8.75M
Average Volume (3m)
659.37K
1-Year Change
-16.89%
Book Value / Share
0.13
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GUTS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.33
Upside
+824.09%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Fractyl Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Fractyl Health Inc Company Profile

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Fractyl Health Inc Earnings Call Summary for Q1/2025

  • R&D expenses rose to $19.4M from $14.4M in Q1 2024, widening net loss to $23.7M from $3.3M
  • Stock dropped 4.52% to $1.69 in aftermarket trading; cash reserves of $42.1M provide runway into Q4 2025
  • Upcoming catalysts: REVEAL one data release, REJUVA one CTA module submission in June, pivotal data in H2 2025
  • CEO emphasizes 2025 as 'defining year,' focusing on scalable outpatient solutions for metabolic resets
  • Despite -71.97% decline over past year, company maintains 3.63 current ratio, indicating strong short-term liquidity
Last Updated: 13/05/2025, 22:24
Read Full Transcript

Compare GUTS to Peers and Sector

Metrics to compare
GUTS
Peers
Sector
Relationship
P/E Ratio
−1.0x−9.1x−0.5x
PEG Ratio
−0.01−0.390.00
Price/Book
14.4x2.8x2.6x
Price / LTM Sales
1,526.4x2.6x3.3x
Upside (Analyst Target)
-76.5%42.8%
Fair Value Upside
Unlock−6.8%6.5%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 9.33
(+824.09% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.475 / -0.41
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

GUTS Income Statement

People Also Watch

16.24
SRPT
-3.04%
6.850
TRON
-1.37%
0.95
KLTO
-2.96%
0.561
WINT
+5.43%
2.76
INMB
+2.60%

FAQ

What Stock Exchange Does Fractyl Health Trade On?

Fractyl Health is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Fractyl Health?

The stock symbol for Fractyl Health is "GUTS."

What Is the Fractyl Health Market Cap?

As of today, Fractyl Health market cap is 91.59M.

What Is Fractyl Health's Earnings Per Share (TTM)?

The Fractyl Health EPS (TTM) is -1.84.

When Is the Next Fractyl Health Earnings Date?

Fractyl Health will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is GUTS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Fractyl Health Stock Split?

Fractyl Health has split 0 times.

How Many Employees Does Fractyl Health Have?

Fractyl Health has 109 employees.

What is the current trading status of Fractyl Health (GUTS)?

As of 06 Aug 2025, Fractyl Health (GUTS) is trading at a price of 1.01, with a previous close of 1.87. The stock has fluctuated within a day range of 0.83 to 1.05, while its 52-week range spans from 0.83 to 3.72.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.